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Immunological competence is known to vary with age, and such age-related
variations are often parabolic in nature. For example, both the level and avidity
of the antibody response increase during postnatal development, reach a maxi-
mum in adulthood, and then decline during senescence (1). Cellular changes in
the T lymphocyte compartment (both helper and suppressor T cell levels) appear
to account for most variations in immunological competence (1, 2). Relatively
few studies have attempted to correlate these functional changes with variations
in the levels and nature of molecules expressed by immunocompetent lympho-
cytes. A study has therefore been undertaken to evaluate the glycosylation status
of IgG during the natural history of human life.
Human serum IgG has been reported to carry at least 30 different N-linked
oligosaccharides, all of which are of the biantennary complex type, and most of
which (>95%) carry N-acetylglucosamine in both outer arms (3, 4). Structural
differences between these arise primarily from core-substitutions (i.e., fucose
and the `bisecting' G1cNAc), outer-arm galactosylation, and sialylation (Fig. 1 a).
We have previously reported that the percentage incidence of agalactosyl struc-
tures on the serum IgG of a group of patients with active rheumatoid arthritis
(mean age 62 yr) was -51%, placing this group well above the average for a
group of normal individuals (3, 5).
We now report that the galactosylation of IgG N-linked oligosaccharide
changes as a parabolic function of age. This seemingly parallels changes in
immunological competence and draws attention to the need to monitor age-
dependent variations in the expression of oligosaccharides in addition to those
related to differences in cell type (6).
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Serum was obtained from 151 individuals of both sexes and varying in age from 1-70
yr. None of the individuals >15 yr old were known to have any pathological abnormal-
ities, nor to have had any history of autoimmune disease, although some of the older
individuals may have had subclinical levels of age-related diseases (such as osteoarthritis),
but none has as yet presented with major symptoms. All children under the age of 15 yr
whowere studied were undergoing ear, nose, and throat surgery, hernia repairs, or treat-
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ment for ,Q-thalassaemia or epilepsy . Parental permission was obtained before studying
any child <18 yr of age .
Total serum IgG was isolated as described previously (3), and the oligosaccharides were
released, isolated, and radioactively labeled, also as described previously (7) .
To determine the relative percentage incidence of agalactosyl, monogalactosyl, and
digalactosyl oligosaccharides, Go, G1 , and G2 , respectively, an aliquot (-5 X 10 5 cpm)
of the unfractionated oligosaccharides isolated from each IgG sample, was incubated for
18 hr at 37°C under a toluene atmosphere with 10 1A of an exoglycosidase mixture con-
taining 50 mU neuraminidase (ex . Arthrobacter ureafaciens; Boehringer-Mannheim Bio-
chemicals, Indianapolis, IN), 40 mU a-fucosidase (ex. bovine epididymis ; Sigma Chemical
Co ., St . Louis, MO), 0.85 U ,Q-N-acetylhexosaminidase (ex. jack bean ; Sigma Chemical
Co .), in the presence of 0.1 mg galactonic acid-y-lactone, in 0 .2 M citrate-phosphate (pH
6.0) . Reaction was terminated by heating to 100'C for 2 min, and an aliquot (^-I%) of
the digestion products was subjected to high-voltage paper electrophoresis (3) . All
radioactivity remained at the origin, indicating complete cleavage of the sialic acid . The
remaining digestion products (-99%) were separated by Bio-Gel P4 (-400 mesh) gel-
permeation chromatography using a 1 .5 X 50 cm column. The regions Go, G1 , and G2
indicated in Fig. 1 b, were pooled and the relative radioactivity within each was
determined .
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(a) Composite structure of the N-
linked oligosaccharides derived from human
serum IgG . Structural differences arise from
the presence or absence of the residues under-
lined (3). (b) Bio-Gel P4 (-400 mesh) gel-per-
meation chromatogram of the digestion prod-
ucts G2 , G,, and Go released from the total
serumIgG of an individual of age 31 yr (Mate-
rials and Methods) . The figure shows radioac-
tivity (vertical axis) plotted against retention
time . Numerical superscripts refer to the elu-
tion volume of glucose oligomers in glucose
units, as detected simultaneously by the refrac-
tive index monitor (data not shown) . (c) Pri-
mary structures of the digalactosyl G2 , mono-
galactosyl G,, and agalactosyl Go digestion
products obtained from the composite oligo-
saccharide structure depicted in Fig. 1 a .
(Materials and Methods) . The structure of the
products was determined by a mixture of
sequential exoglycosidase digestion and meth-
ylation analysis, as reported elsewhere (3, 4) .
Product G2 is generated from all structures
that originally carried two outer-arm galactose
residues, G, from all structures that originally
carried one outer-arm galactose residue, and
G from all structures that were originally
agalactosyl .Results
The extent of the outer-arm galactosylation of the N-linked oligosaccharides
released from each serum IgG sample was determined enzymatically as shown
in Fig. 1 b. This determination involves the simultaneous use of a mixture of
specific exoglycosidases, and leads to the conversion of each IgG-associated oli-
gosaccharide into one of three digestion products in a manner dependent only
on its outer-arm galactosylation. Specifically, all digalactosyl structures (i.e., nei-
ther outer-arm terminating in N-acetylglucosamine or mannose) reduce to or
remain as product G2, all monogalactosyl ones (i.e., one outer arm terminating
in N-acetylglucosamine or mannose) to product GI, and all agalactosyl ones (i.e.
both outer arms terminating in N-acetylglucosamine or mannose) to product Go
(see Fig. 1 c) . These three products are all completely resolved by Bio-Gel P4
(-400 mesh) gel-permeation chromatography, and the relative radioactivity
within each of the three peaks gives a direct measure of the relative incidence
of digalactosyl, monogalactosyl, and agalactosyl oligosaccharides in the original
pool of oligosaccharides released from each sample of IgG. The results obtained
using this enzymatic method are extremely reproducible (<1% variation for a
given IgG sample).
The results for the incidence of agalactosyl and monogalactosyl structures are
presented graphically in Fig. 2. It is clear that the relative incidence of agalac-
tosyl structures on total human serum IgG varies continuously with age, but the
relative incidence of monogalactosyl moieties is remarkably constant. The inci-
dence of digalactosyl structures varied parabolically and inversely to that of aga-
lactosyl structures. Differences between the sexes in galactosylation of IgG oli-
gosaccharides were not significant (data not shown) . The IgG-associated
structures from 34 selected individuals varying in age from 18 to 63 yr were
analyzed with respect to sialylation, outer-arm N-acetylglucosaminylation, and
core substitutions (3). None of these parameters varied with age, suggesting that
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(a) Relation of the percentage incidence of agalactosyl monosac-
charide sequences Go to age for IgG from normal subjects. The solid curve
depicts the regression function for normal subjects generated by the least
squares method and is given by the equation y = 27.8 - 0.49x -f 0.91 X
10-Y, n = 151 . The dashed curves represent the 95% confidence bounds
of the fit. (b) Relation of the percentage incidence of monogalactosyl mon-
osaccharide sequences G, to age for IgG from normal subjects. The solid
line depicts the regression line of the data, (individual values are notshown).
The dashed lines represent the 95% confidence bounds for the least squares
Agelyears) fit.1734
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only outer-arm galactosylation is age related. It should be emphasized that in no
case was there any evidence for a novel IgG-associated N-linked oligosaccharide,
but rather a continuous variation in the relative incidence of a constant set of
structures. The incidence of structures with both outer arms terminating in N-
acetylglucosamine first decreases with age (from >30% to ^-20% at 25 yr) and
then increases continuously to reach a level of ^"40% by 70 yr of age. This
would correspond to a nearly fourfold increase in those serum IgG molecules
whose Fc may be presumed to be totally devoid of galatose between 25 and 70
yr of age. Further, there is limited but significant variation in the incidence of
agalactosyl oligosaccharides within an age group.
Discussion
Both polypeptide structure and cell type have been shown to influence the N-
glycosylation of secreted and cell surface glycoproteins (6). The results pre-
sented here indicate that within a cellular population (i.e., B lymphocytes), gal-
actosylation of the outer arms of the N-linked oligosaccharides of a secreted
glycoprotein (i.e. IgG) varies continuously with age. This variation differs from
previously reported age-dependent molecular parameters (8, 9), such as glucose
mediated crosslinking of proteins (9), in so far as it appears to be a continuous
and natural process applied to a serum protein, of relatively short half-life, in a
manner independent of the level of that protein.
The molecular basis for this variation is not yet known, but it could be due to
a naturally age-related expression of ,Q-galactosyltransferase (or )3-galactosidase)
activity within all B lymphocytes (e.g., epigenetic error at the DNA level [10] or
extrinsic factors [8]) . Alternatively, certain clones of B lymphocytes, differing
with respect to their N-glycosylation capacity (glycotype), may dominate at dif-
ferent developmental stages of the immune system. The latter is consistent with
the increased frequency of idiopathic paraproteinemias during aging (11). The
variations observed within an age group could arise from different genetic
endowments, or they could be a response to extrinsic factors. Further studies
are needed to define the molecular basis of these variations .
The high incidence of agalactosyl IgG in the serum of young children may
indicate a particular N-glycosylation capacity of B lymphocytes in children. It is
especially interesting that in children with juvenile rheumatoid arthritis, the high
incidence of agalactosyl structures found during the early years after birth is
maintained and does not return to normal until periods of sustained remission
(5). It has recently been reported that human B lymphocytes that secrete rheu-
matoid factor (largely IgM, but also IgG) are of the Leu-l+ (OKT 15; CD5)
phenotype, and that they are particularly prevalent both in patients with rheu-
matoid arthritis and in cord blood (12, 13). The results presented here and pre-
viously raise the possibility that Leu 1-I- B-lymphocytes may also be character-
ised by a particular N-glycosylation capacity. Paradoxically the increased
frequency of autoantibodies and rheumatoid factor are characteristic of surviv-
ing older humans (14).
Finally, there is increasing evidence that the precise N-linked oligosaccharides
carried by immunoglobulins can significantly affect its functional properties (4,
15). If the results presented here are generally valid, and N-glycosylation ofPAREKH ET AL.
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other glycoproteins does vary with the age of the individual, then biological
functions influenced by carbohydrates must presumably also be affected. For
example, the activity of the insulin receptor is influenced by the oligosaccharides
it carries (16). The migration of lymphocytes is also dependent on cell surface
N-linked oligosaccharides, suggesting that changes in N-glycosylation may be
responsible for the unique property of the inflamed synovium in patients with
rheumatoid arthritis due to direct extravasation of T lymphocytes (17) . Age
related variations in oligosaccharide-mediated functions may, in some cases, be
the basis for the age-association of certain diseases. This raises the possibility
that one lesion in rheumatoid arthritis may be an accelerated aging process
within the B lymphocyte compartment of affected individuals. Studies are there-
fore underway to follow variations with age in the N-glycosylation of other gly-
coproteins, and in particular the biological consequences of the varying expo-
sure of nonreducing terminal N-acetylglucosamine residues with aging (18) .
Summary
In a study of 151 normal, healthy individuals of both sexes varying in age
from 1-70 yr, it was found that the relative incidence of agalactosyl (with both
outer arms terminating in N-acetylglucosamine) N-linked oligosaccharides on
total serum IgG decreased from birth to a minimum (at 25 yr of age) and then
increased with age. The relative incidence of digalactosyl structures varied
inversely to this, and the relative incidence of monogalactosyl structures was
constant. Galactosylation of the N-linked oligosaccharides of the human serum
IgG of normal individuals is therefore an age-related molecular parameter. Sev-
eral reports have suggested that rheumatoid arthritis is associated with a
decreased galactosylation of serum IgG (3-5). The normal variation in galacto-
sylation with age as described here allows a true assessment of disease-associated
changes in this parameter, and raises the possibility that one of the lesions in
rheumatoid arthritis is an accelerated aging of the immune system. In addition,
heterogeneity within age groups may be due to intrinsic differences in genetic
endowment, or may reflect the impact of extrinsic factors (8).
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